Liquid biopsy assay model identifies high-risk CRC to avoid unnecessary surgeries

Liquid biopsy assay model identifies high-risk CRC to avoid unnecessary surgeries

A novel risk-stratification model developed for noninvasive identification of T1 colorectal cancer may help avoid unnecessary surgeries for high-risk patients.“Pending validation in future prospective studies, our findings highlight the potential clinical impact of our model for improved selection of patients with high-risk T1 CRC, which will reduce the overall burden of unnecessary surgeries and expense associated with these procedures, and improve the overall management of patients with this malignancy,” Yuma Wada, from the Center for Gastrointestinal Research, Baylor Scott &Read More

Share on facebook
Share on twitter
Share on linkedin